suramin has been researched along with cyclosporine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Aszalos, A; Pine, PS; Weaver, JL | 1 |
Iñiguez, C; Larrodé, P; Mauri, JA; Mayordomo, JI; Morales, F; Trés, A | 1 |
Bernardes, CF; Castilho, RF; Fagian, MM; Meyer-Fernandes, JR; Vercesi, AE | 1 |
Burbiel, JC; Bylund, J; Christenson, K; Dahlgren, C; Forsman, H; Gabl, M; Müller, CE; Önnheim, K; Oprea, TI | 1 |
1 review(s) available for suramin and cyclosporine
Article | Year |
---|---|
[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] .
Topics: Anti-HIV Agents; Antineoplastic Agents; Cyclosporine; Depsipeptides; Docetaxel; Doxorubicin; Humans; Neoplasms; Neuromuscular Diseases; Oligopeptides; Organoplatinum Compounds; Paclitaxel; Peripheral Nervous System Diseases; Procarbazine; Reverse Transcriptase Inhibitors; Suramin; Taxoids; Vinca Alkaloids | 2000 |
7 other study(ies) available for suramin and cyclosporine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
Topics: Antibodies, Monoclonal; Benzoquinones; CD28 Antigens; Cells, Cultured; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Interleukin-2; Lactams, Macrocyclic; Lymphocytes; Mycophenolic Acid; Polyenes; Quinones; Receptors, Antigen, T-Cell; Rifabutin; Sirolimus; Suramin; Tacrolimus | 1994 |
Suramin inhibits respiration and induces membrane permeability transition in isolated rat liver mitochondria.
Topics: Adenosine Diphosphate; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Membrane Permeability; Cell Respiration; Chelating Agents; Cyclosporine; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Ethylmaleimide; Intracellular Membranes; Magnesium; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Oxygen Consumption; Rats; Rats, Wistar; Sulfhydryl Reagents; Suramin; Trypanocidal Agents | 2001 |
A novel receptor cross-talk between the ATP receptor P2Y2 and formyl peptide receptors reactivates desensitized neutrophils to produce superoxide.
Topics: Actin Cytoskeleton; Adenosine Triphosphate; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cyclosporine; Enzyme Inhibitors; Humans; Marine Toxins; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oxazoles; Phosphoprotein Phosphatases; Purinergic P2Y Receptor Antagonists; Receptors, Formyl Peptide; Receptors, Purinergic P2Y2; Signal Transduction; Superoxides; Suramin; Thiazolidines | 2014 |